Arbutus Biopharma (ABUS) and Genevant Sciences, a subsidiary of Roivant Sciences (ROIV), on Thursday announced the filing of three international lawsuits over a patent dispute related to Pfizer (PFE) ...

As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new ...

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid ...

Arbutus Biopharma and its licensee Genevant filed three patent infringement lawsuits against Pfizer and BioNTech for its lipid nanoparticle technology. The clinical-stage biopharmaceutical company is ...

Warminster-based Arbutus Biopharma has cranked up its legal war over COVID‑19 vaccine delivery technology, rolling out a new ...

The aim of the study is to understand if the combination of the vaccines is safe, and the immune response after adding the ...

(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly ...

Add Yahoo as a preferred source to see more of our stories on Google. Pfizer Inc. signage is seen on July 22, 2020 in New York City. (Jeenah Moon via Getty Images) This story was originally published ...

Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations. The US drugmaker is offering about 4.55 ...

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their ...